Credit Suisse initiated coverage of Cabot with a rating of Outperform and set a new price target of $94.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/11/2024 | $105.00 | Neutral → Underweight | JP Morgan |
| 4/18/2024 | Buy → Hold | Deutsche Bank | |
| 3/27/2024 | $104.00 | Buy | Mizuho |
| 1/8/2024 | $90.00 → $87.00 | Buy → Neutral | UBS |
| 6/6/2023 | $87.00 → $80.00 | Overweight → Neutral | JP Morgan |
| 3/13/2023 | $94.00 | Outperform | Credit Suisse |
| 11/16/2022 | $80.00 → $90.00 | Hold → Buy | Deutsche Bank |
| 1/4/2022 | $75.00 → $70.00 | Buy | UBS |
Cabot Corporation (NYSE:CBT) announced today that Thierry Vanlancker has been elected to its Board of Directors, effective July 12, 2024. He was also appointed a member of the Audit Committee of the Board of Directors, effective July 12, 2024. Prior to his retirement, Mr. Vanlancker was Chief Executive Officer and a Director of AkzoNobel NV, a multinational paints and coatings company, from 2017 to 2022. Prior to joining AkzoNobel, Mr. Vanlancker was President of Fluoroproducts and the EMEA region at The Chemours Company, a global provider of performance chemicals, from 2015 to 2016, and from 1988 to 2015 held various positions within the chemicals company Dupont. Mr. Vanlancker has been a
19 Carbon Black Facilities Across Global Network Receive Safety Awards Cabot Corporation (NYSE:CBT) today announced that 19 of its 20 carbon black manufacturing sites have been recognized by the International Carbon Black Association's (ICBA) Safety Performance Recognition Program. Across the company's global network, 18 of its carbon black facilities received the gold award, the highest recognition available, and one received the bronze award for their outstanding safety performance in 2023. For the industry overall, a total of 35 ICBA member manufacturing facilities were recognized for above average safety performance, with Cabot achieving over half of all awards granted as well as the
Cabot Corporation (NYSE:CBT) announced today that Michelle Williams, Ph.D., has been elected to its Board of Directors, effective September 13, 2023. She was also appointed a member of the Audit Committee of the Board of Directors, effective September 13, 2023. Prior to her retirement in 2021, Dr. Williams was Global Group President of Altuglas International, a manufacturer of polymethyl methacrylate (PMMA) and a subsidiary of Arkema S.A., a manufacturer of specialty chemicals and advanced materials. Dr. Williams has been a Director of Brady Corporation, a manufacturer and supplier of identification solutions and workplace safety products, since 2019, where she serves as Chair of the Techno
JP Morgan downgraded Cabot from Neutral to Underweight and set a new price target of $105.00
Deutsche Bank downgraded Cabot from Buy to Hold
Mizuho initiated coverage of Cabot with a rating of Buy and set a new price target of $104.00
10-K - CABOT CORP (0000016040) (Filer)
8-K - CABOT CORP (0000016040) (Filer)
10-Q - CABOT CORP (0000016040) (Filer)
On Friday, November 8, 2024, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.43 per share on all outstanding shares of the Corporation's common stock. The dividend is payable on December 13, 2024, to stockholders of record at the close of business on November 29, 2024. About Cabot Corporation Cabot Corporation (NYSE:CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For mo
Fourth Quarter 2024 Diluted earnings per share ("EPS") of $2.43 and Adjusted EPS of $1.80 Fiscal Year 2024 Diluted EPS of $6.72 and Adjusted EPS of $7.06 Cabot Corporation (NYSE:CBT) today announced results for its fourth quarter and fiscal year 2024. Fiscal Year Highlights Fiscal year Diluted EPS of $6.72 and Adjusted EPS of $7.06, which represents a 31% increase in Adjusted EPS year over year, driven by EBIT growth in both segments Fiscal year segment EBIT increased 11% in Reinforcement Materials and 31% in Performance Chemicals year-over-year Fiscal year 2024 Cash Flows from Operations of $692 million enabled capital investments of $241 million and the payment of $93 million in d
Cabot Corporation (NYSE:CBT) announced today that it will host an Investor Day for institutional investors and financial analysts on Wednesday, December 4, 2024, at 9:00 a.m. Eastern Time. Sean D. Keohane, President and CEO, and members of the executive management team will provide insights into the Company's strategy, key growth initiatives, sustainability leadership, and the next set of long-term financial targets strategies. The event will take place at The Westin Boston Seaport District in Boston, Massachusetts and will also be available virtually. To register for in-person or virtual attendance, please use the following link: Register for 2024 Investor Day. A live webcast, including
4 - CABOT CORP (0000016040) (Issuer)
4 - CABOT CORP (0000016040) (Issuer)
4 - CABOT CORP (0000016040) (Issuer)
SC 13G/A - CABOT CORP (0000016040) (Subject)
SC 13G/A - CABOT CORP (0000016040) (Subject)
SC 13G/A - CABOT CORP (0000016040) (Subject)
On Friday, November 8, 2024, the Board of Directors of Cabot Corporation (NYSE:CBT) declared a quarterly dividend of $0.43 per share on all outstanding shares of the Corporation's common stock. The dividend is payable on December 13, 2024, to stockholders of record at the close of business on November 29, 2024. About Cabot Corporation Cabot Corporation (NYSE:CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company is a leading provider of reinforcing carbons, specialty carbons, battery materials, engineered elastomer composites, inkjet colorants, masterbatches and conductive compounds, fumed metal oxides and aerogel. For mo
Fourth Quarter 2024 Diluted earnings per share ("EPS") of $2.43 and Adjusted EPS of $1.80 Fiscal Year 2024 Diluted EPS of $6.72 and Adjusted EPS of $7.06 Cabot Corporation (NYSE:CBT) today announced results for its fourth quarter and fiscal year 2024. Fiscal Year Highlights Fiscal year Diluted EPS of $6.72 and Adjusted EPS of $7.06, which represents a 31% increase in Adjusted EPS year over year, driven by EBIT growth in both segments Fiscal year segment EBIT increased 11% in Reinforcement Materials and 31% in Performance Chemicals year-over-year Fiscal year 2024 Cash Flows from Operations of $692 million enabled capital investments of $241 million and the payment of $93 million in d
Cabot Corporation (NYSE:CBT) announced today that it will release operating results for the fourth quarter of fiscal 2024 on Monday, November 4, 2024, after market close. The Company will host a conference call and live webcast to review the fourth quarter results beginning at 8:00 am (ET) on Tuesday, November 5, 2024. The call will be webcast by Notified and may be accessed at Cabot's website at https://cabotog.gcs-web.com/. If you are unable to participate during the live webcast, the call and accompanying slide presentation will be archived on the Company's website at https://cabotog.gcs-web.com/. ABOUT CABOT CORPORATION Cabot Corporation (NYSE:CBT) is a global specialty chemicals and
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Cabot (NYSE:CBT) in the last three months. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 0 2 0 0 Last 30D 1 0 1 0 0 1M Ago 0 0 1 0 0 2M Ago 1 0 0 0 0 3M Ago 0 0 0 0 0 Analysts have recently evaluated Cabot and provided 12-month price targets. The average target is $102.75, accompanied by a high estimate of $109.00 and a low estimate of $95.00. Observing a 5.57% increase, the current avera
UBS analyst Joshua Spector maintains Cabot (NYSE:CBT) with a Neutral and raises the price target from $100 to $103.
Mizuho analyst John Roberts maintains Cabot (NYSE:CBT) with a Buy and raises the price target from $104 to $109.